Diametric Capital’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-50,875
| Closed | -$76.3K | – | 412 |
|
|
2023
Q1 | $76.3K | Buy |
+50,875
| New | +$76.3K | 0.04% | 286 |
|
|
2021
Q2 | – | Sell |
-26,712
| Closed | -$63K | – | 166 |
|
|
2021
Q1 | $63K | Buy |
+26,712
| New | +$63K | 0.05% | 144 |
|
|
2020
Q3 | – | Sell |
-23,567
| Closed | -$21K | – | 152 |
|
|
2020
Q2 | $21K | Buy |
+23,567
| New | +$21K | 0.02% | 139 |
|